Related Experiment Video
Updated: Jul 16, 2026
06:14
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
Oncolytic herpes simplex virus type 1 and host immune responses
Hiroshi Fukuhara1, Tomoki Todo
1Department of Urology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Current Cancer Drug Targets
|March 10, 2007
Summary
Oncolytic herpes simplex virus type 1 (HSV-1) shows promise for cancer therapy. Its effectiveness relies on stimulating antitumor immune responses, highlighting the need to understand the immune system's role in viral oncolysis.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Oncolytic herpes simplex virus type 1 (HSV-1) is an emerging cancer treatment strategy.
- The efficacy of oncolytic HSV-1 therapy is linked to its replication within tumors and its ability to stimulate host antitumor immune responses.
Purpose of the Study:
- To explore the role of the host immune system in enhancing the efficacy of oncolytic HSV-1 therapy for cancer treatment.
- To discuss strategies for modulating immune responses to improve oncolytic viral therapy.
Main Methods:
- Reviewing existing evidence on oncolytic HSV-1 and host immune interactions.
- Investigating methods to modify immune responses, including using HSV-1 as a vector for immunostimulatory molecules and co-administering immune-modulating reagents.
- Considering temporary suppression of innate immunity to enhance viral propagation.
Main Results:
- Oncolytic HSV-1 efficacy is significantly influenced by the induction of host antitumor immune responses.
- Strategies like expressing immunostimulatory molecules via HSV-1 vectors and using immune-modulating agents can enhance therapeutic outcomes.
- Temporary suppression of innate immunity may improve viral replication within tumors.
Conclusions:
- Understanding the host immune system's role is critical for advancing oncolytic HSV-1 therapy.
- Modulating immune responses and optimizing viral propagation are key to establishing oncolytic HSV-1 as a viable clinical cancer treatment.
Related Concept Videos
01:28Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...